MEGX test in hepatology: The long-sought ultimate quantitative liver function test?
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 19 (1) , 4-7
- https://doi.org/10.1016/s0168-8278(05)80169-2
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Assessment of lidocaine metabolite formation in comparison with other quantitative liver function testsJournal of Hepatology, 1993
- Measuring lidocaine metabolite — monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosisJournal of Hepatology, 1993
- Monoethylglycinexylide Formation in Assessing Pediatric Donor Liver FunctionTherapeutic Drug Monitoring, 1992
- Predictors of one-year pretransplant survival in patients with cirrhosisHepatology, 1991
- LIGNOCAINE METABOLITE FORMATION AS A MEASURE OF PRE-TRANSPLANT LIVER FUNCTIONThe Lancet, 1989
- Prognostic value of indocyanine green and lidocaine kinetics for survival and chronic hepatic encephalopathy in cirrhotic patients following elective end-to-side portacaval shuntHepatology, 1988
- The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: Correlation with morphometric measurement of hepatocyte massHepatology, 1987
- Monoethylglycinexylidide Formation Kinetics: A Novel Approach to Assessment of Liver Functioncclm, 1987
- Clinical Pharmacokinetics of LignocaineClinical Pharmacokinetics, 1978
- Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.BMJ, 1977